Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Myasthenia Gravis 3Leukemia 3Myelodysplastic Syndromes 2Lymphoma 2Graft vs Host Disease 2Thymic aplasia 1Skin Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Immunologic Deficiency Syndromes 1Hodgkin Disease 1Hematologic Neoplasms 1Erectile Dysfunction 1Dermatitis, Atopic 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Tadalafil 1Tacrolimus 1GPI 1485 1Cyproterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Erectile Dysfunction × Tacrolimus × Clear all
NCT00106392 2010-11-23

A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy

Astellas Pharma Inc

Phase 4 Completed
131 enrolled 13 charts
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡